Antihypertensive Drug Linked to Lower Long-Term Risk of Gout
Amlodipine lowered the risk of gout when compared with 2 other antihypertensive medications.
FDA Approves Ferric Derisomaltose Injection for Iron Deficiency Anemia
Officials with the FDA have approved ferric derisomaltose (Monoferric, Pharmacosmos Therapeutics Inc.) injection 100 mg/mL.
FDA Grants Priority Review to Dupilumab for Children with Atopic Dermatitis
If approved, dupilumab (Dupixent, Regeneron and Sanofi) would be indicated for use as an add-on maintenance treatment for children ages 6 to 11 years with moderate-to-severe atopic dermatitis.
Phase 3 Study Shows Ticagrelor Plus Aspirin Reduces Risk of Stroke, Death
Ticagrelor (Brilinta, AstraZeneca) reduced the risk of stroke and death when taken with aspirin compared with aspirin alone.
FDA OKs Fidaxomicin Oral Suspension, Tablets for Pediatric C. Difficile
Fidaxomicin (Dificid, Merck) is indicated in adults and pediatric patients aged 6 months and older for the treatment of Clostridioides difficile-associated diarrhea.
CDC: 2 Novel Coronavirus Cases Reported in US, Risk to Public Is Still Low
The 2019 Novel Coronavirus outbreak in Wuhan City, China has caused concern as 2 cases have been recently reported in the United States.
AGA Releases New Guidelines on Management of Ulcerative Colitis
Evidence-based recommendations focus on immunomodulators, biologics, and small molecules for the management of ulcerative colitis.
Pfizer Announces US Launch of 3 New Oncology Biosimilars
Pfizer announced the introduction of 3 new oncology biosimilars to the US market at a substantially discounted price.
Short-Term Cannabis Use May Help Patients With Chronic Pain Maintain Sleep
Patients with chronic pain using medical cannabis reported less nighttime awakenings initially, but tolerance may build with frequent use.
Preemptive Pain Management Reduces Opioid Use After Minimally Invasive Surgery
A preemptive pain management program involving OTC medications can help reduce the need for opioid prescriptions following certain surgeries.
Lefamulin (Xenleta) for Community Acquired Bacterial Pneumonia
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
Olaparib Granted Priority Review for HRR-Mutated Metastatic Castration-Resistant Prostate Cancer
FDA approval decision expected in the second quarter of 2020.
PPI Use May Affect Cognition in Individuals Previously Treated for Breast Cancer
Proton pump inhibitors (PPIs) may be linked to concentration and memory problems in individuals with a history of breast cancer.
Sunosi for Excessive Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
FDA OKs Cardiovascular Risk Reduction Indication for Semaglutide
The FDA has approved semaglutide (Ozempic, Novo Nordisk) for the reduction of major adverse cardiovascular (CV) events in patients with type 2 diabetes and established CV disease.
What Pharmacists Need to Know About Psoriasis Medications
Pharmacists can play an integral role in managing patients with psoriasis through medication therapies and lifestyle modifications.
Diabetes a Serious Risk Factor for Herpes Zoster
Shingles vaccination recommended by CDC and ADCES.
Effect of Long-Term Antipsychotic Use on Morbidity, Mortality Risk
Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study.
Most Valuable Drugs in the 2020 Pipeline
Here are the top drugs expected to be approved this year.
Cardiovascular Disease Linked to Increased Risk of Kidney Failure
Individuals with a history of heart disease may be at an increased risk of developing kidney failure.
WHO Insulin Prequalification Program to Expand Access
Cancer Mortality Continues Decline, Progress Driven by New Treatments
Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.
Prediabetes On the Rise Among US Teens and Young Adults
Prediabetes can increase the risk the risk of developing type 2 diabetes.
Intensive or Standard Blood Pressure Control for Patients Aged 80 and Older
Are the benefits of lowering systolic blood pressure to less than 130 mm Hg the same for those aged 80 years and older as they are for younger patients?
Dapagliflozin Granted Priority Review for Heart Failure with Reduced Ejection Fraction
AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.
FDA OKs Fast-Acting Insulin Aspart Injection for Children with Diabetes
Insulin aspart injection (Fiasp, Novo Nordisk) has been approved for use as a new mealtime insulin option for children with diabetes.
FDA Issues Complete Response Letter to Investigational Long-Acting HIV Regimen
The New Drug Application is seeking approval for ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV in adults.
Novo Nordisk Announces New Insulin Affordability Options
Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.
Diabetes an Independent Risk Factor for Heart Failure
A new study examined diabetes as an independent predictor of heart failure.
FDA Approves Maintenance Olaparib for Metastatic Pancreatic Cancer
Olaparib (Lynparza, Merck and AstraZeneca) is approved for the maintenance treatment of adult patients with germline BRCA-mutated metastatic pancreatic cancer.
